The role of Helicobacter pylori in children with chronic idiopathic thrombocytopenic purpura
- PMID: 18176181
- DOI: 10.1097/MPH.0b013e3181615613
The role of Helicobacter pylori in children with chronic idiopathic thrombocytopenic purpura
Abstract
Recent reports have suggested that Helicobacter pylori infection may be a causative agent of adult chronic idiopathic thrombocytopenic purpura (cITP) and antimicrobial treatment may increase platelet counts. As there is limited experience in pediatric age, we investigated the prevalence of H. pylori infection and the effects of H. pylori eradication therapy in a series of children with cITP. Twenty-four children with cITP were investigated for H. pylori infection using the C-urea breath test or H. pylori fecal antigen. In cases of H. pylori infection, antimicrobial treatment was given with amoxicillin, clarithromycin, and proton pump inhibitors. Response was assessed at 6 months and defined as complete (platelet count >150x10/L) or partial (platelet count between 50 and 150x10/L). H. pylori infection was found in 8 patients (33%) and 3 of them showed a response after eradication therapy, but 2 of them relapsed later on. Two patients had a spontaneous increase in platelet count in the group of H. pylori-negative patients. Given that spontaneous improvements in platelet count can occur in children with cITP, we were unable to demonstrate that H. pylori plays a major role in cITP occurring in pediatric age.
Similar articles
-
Helicobacter pylori infection in children with chronic idiopathic thrombocytopenic purpura.J Pediatr Hematol Oncol. 2008 Jan;30(1):96-7. doi: 10.1097/MPH.0b013e3181615600. J Pediatr Hematol Oncol. 2008. PMID: 18176194 No abstract available.
-
Effect of Helicobacter pylori eradication in patients with chronic idiopathic thrombocytopenic purpura-a randomized controlled trial.Am J Gastroenterol. 2005 Jun;100(6):1265-70. doi: 10.1111/j.1572-0241.2005.41641.x. Am J Gastroenterol. 2005. PMID: 15929755 Clinical Trial.
-
Eradication of Helicobacter pylori increases platelet count in patients with idiopathic thrombocytopenic purpura in Japan.Eur J Clin Invest. 2005 Mar;35(3):214-9. doi: 10.1111/j.1365-2362.2005.01471.x. Eur J Clin Invest. 2005. PMID: 15733077
-
[Helicobacter pylori infection and idiopathic thrombocytopenic purpura].Nihon Rinsho. 2003 Apr;61(4):644-9. Nihon Rinsho. 2003. PMID: 12718090 Review. Japanese.
-
Helicobacter pylori infection and immune thrombocytopenic purpura: an update.Helicobacter. 2004 Aug;9(4):342-6. doi: 10.1111/j.1083-4389.2004.00238.x. Helicobacter. 2004. PMID: 15270749 Review.
Cited by
-
Helicobacter pylori-associated immune thrombocytopenia: clinical features and pathogenic mechanisms.World J Gastroenterol. 2014 Jan 21;20(3):714-23. doi: 10.3748/wjg.v20.i3.714. World J Gastroenterol. 2014. PMID: 24574745 Free PMC article. Review.
-
Helicobacter pylori infection and extragastric disorders in children: a critical update.World J Gastroenterol. 2014 Feb 14;20(6):1379-401. doi: 10.3748/wjg.v20.i6.1379. World J Gastroenterol. 2014. PMID: 24587617 Free PMC article. Review.
-
Current views of the relationship between Helicobacter pylori and Henoch-Schonlein purpura in children.World J Clin Pediatr. 2016 Feb 8;5(1):82-8. doi: 10.5409/wjcp.v5.i1.82. eCollection 2016 Feb 8. World J Clin Pediatr. 2016. PMID: 26862506 Free PMC article. Review.
-
Consequences of Helicobacter pylori infection in children.World J Gastroenterol. 2010 Nov 7;16(41):5181-94. doi: 10.3748/wjg.v16.i41.5181. World J Gastroenterol. 2010. PMID: 21049552 Free PMC article. Review.
-
Efficacy of Helicobacter pylori Eradication Therapy on Platelet Recovery in Pediatric Immune Thrombocytopenic Purpura-Case Series and a Systematic Review.Microorganisms. 2020 Sep 23;8(10):1457. doi: 10.3390/microorganisms8101457. Microorganisms. 2020. PMID: 32977477 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials